Skip to main content
. 2018 Nov 10;7(11):434. doi: 10.3390/jcm7110434

Table 1.

Summary of randomized placebo-controlled trials of aromatherapy for dysmenorrhea (pain).

First Author
(Year)
[Ref]
Country
Sample Size;
Age (years);
Severity
Intervention Control Treatment Duration Result Comments
Design/AEs
Uysal
(2016)
[16]
Turkey
105
19–30
Pain on VAS ≥5
(A) Rose oil (Inhalation, <1 m above patients, n = 52), plus diclofenac sodium (75 mg) (B) Placebo (saline, <1 m above patients, n = 53), plus diclofenac sodium (75 mg) 1 time (10–30 min) p < 0.01 in favor of aromatherapy Diclofenac 75 mg
Treatment time is not clear
Parallel/n.r.
Raisi Dehkordi
(2014)
[17]
Iran
96
18–28
Mild or moderate (AMVMS)
(A) Lavender (Inhalation, 7–10 from the nose, rub their palm with aroma oil, n = 48) (B) Placebo (sesame oil, same methods with A, n = 48) 5 min (1 h after experiencing dysmenorrhea) every 6 h for the 1st 3 days of menstruation, one or two treatments in 2 consecutive menstrual cycle p < 0.01 in favor of aromatherapy Not validated questionnaire
Retrospective registration
Parallel/n.r.
Nikjou (2017)
[18]
Iran
200
19–30
n.r.
(A) Lavender (Inhalation, 3 drops, n = 100) (B) Placebo (diluted milk, same methods with A, n = 100) 30 min (0.5 h after experiencing dysmenorrhea) for the 1st 3 days of menstruation, one treatment in 2 consecutive menstrual cycle p < 0.01 in favor of aromatherapy Registration while recruiting
Parallel/n.r.
Choi
(2009)
[19]
Korea
74
not clear
Pain on VAS ≥7
(A) Lavender (Inhalation, n = 18)
(B) Lavender (Massage abdomen, n = 24)
(C) Placebo (vitamin C, same methods with A, n = 15)
(D) Placebo (Massage, almond oil, n = 17)
Wearing necklace for the daytime during the menstruation
Massage was done 10 min once a day for 1 menstrual cycles
NS Parallel/n.r.
Davari (2014)
[20]
Iran
150
18–29
Mild or moderate MDQ
(A) Lavender (Inhalation, n = 28)
(B) Rosemary (Inhalation, n = 29)
(C) Lavender and rosemary (Inhalation, n = 29)
(D) Placebo (n = 30)
(E) mefenamic acid (n = 28)
Twice daily for 3 days the start of menstruation p < 0.001, in favor of aromatherapy Parallel/n.r.
Iravani (2009)
[21]
Iran
108
18–24
Moderate to severe
(A) Zataria Multiflora (Inhalation, 1%, 25 drops, n = 36)
(B) Zataria Multiflora (Inhalation, 2%, 25 drops, n = 36)
(C) Placebo (Inhalation, 25 drops, n = 36) 25 drops every 4 h from the beginning of pain for 3 cycles p < 0.001 in favor of aromatherapy Parallel/n.r.
Salmalian (2014)
[22]
Iran
84
18–24
Mild or moderate
(A) Thymus vulgaris (Inhalation, 25 drops, n = 28), plus placebo capsule (B) Placebo (Inhalation, n.r., n = 28), plus placebo capsule
(C) Ibuprofen (200 mg capsule, n = 28), plus placebo oil
25 drops every 6 h on 1st day of menstrual cycle and the beginning of pain for 2 consecutive cycles p < 0.001 in favor of aromatherapy Triple-blind but no reporting of details
Registration while recruiting
Parallel/n.r.
Bakhtshirin (2015)
[23]
Iran
80
18–24
Pain on VAS ≥6
(A) Lavender oil (Massage abdomen, n = 80) (B) Placebo (Massage abdomen, n = 80) 15 min for 1 cycle (2nd and 3rd cycle)
by nursing and midwifery students
p < 0.001 in favor of aromatherapy 1 cycle washout period
Cross-over/n.r.
Apay
(2012)
[24]
Turkey
44
20.3 ± 1.1
Pain on VAS ≥6
(A) Lavender oil (Massage abdomen, n = 44) (B) Placebo (Massage odorless liquid petrolatum, n = 44) 15 min for 1 cycle (2nd and 3rd cycle) p < 0.001 in favor of aromatherapy 1 cycle washout period
Cross-over/n.r.
Beiranvand
(2015)
[25]
Iran
60
18–26
Pain on VAS >5
(A) Lavender oil (Massage, 2 drops in 2.5 cc of almond oil, 15 min, n = 30) (B) Placebo (Massage with almond oil only, n = 30) 48 h before and after menstruation.
Massage was done 15 min twice a day for two menstrual cycles above the pubic area
p < 0.001 in favor of aromatherapy Retrospective registration
Parallel/n.r.
Sadeghi
(2015)
[26]
Iran
75
18–35
Pain on VAS ≥5
(A) Rose oil (Massage, n = 25) (B) Placebo (Massage, almond oil, unscented, n = 25)
(C) Massage only (n = 25)
1 time, 5 drops, 15 min on the 1st day of menstruation
Self-massage
p < 0.005 in favor of aromatherapy Registration while recruiting
Parallel/None
Rizk
(2013)
[27]
Egypt
120
17–21
Moderate to severe
(A) Peppermint oil (Massage abdomen, n = 40)
(B) Ginger oil (massage, n = 40)
(C) Placebo (Massage abdomen, almond, n = 95) 15 min daily for 5 days for 2 cycles p < 0.001 in favor of aromatherapy Parallel/n.r.
Marzouk
(2013)
[28]
Egypt
95
17–20
Pain on VAS ≥6
(A) Essential oils (cinnamon, clove, rose and lavender, massage, n = 95) (B) Placebo (Massage abdomen, sweet almond, n = 95) Once daily, 10 min for 7 days before menstruation
by a researcher in a student clinic
p = 0.006 in favor of aromatherapy 1 cycle washout period
Cross-over/n.r.
Amiri Farahani
(2012)
[29]
Iran
90
21
verbal multi-dimensional scoring system ≥2
(A) Essential oils (Massage, lavender oil 2% (2 drops), peppermint oil 2% (2 drops) in 4 mL of almond oil, n = 30) (B) Placebo (Massage, almond oil, n = 30)
(C) Massage only (n = 30)
A week before the start of menstrual cycle until the presence of pain, massage at the top of pubic area for 15 min per day.
To be repeated for two cycles
p = 0.03 in favor of aromatherapy Retrospective registration
Parallel/n.r.
Han
(2006)
[30]
Korea
75
19–26
Pain on VAS ≥6
(A) Essential oils (Massage abdomen, lavender, clary sage, rose, n = 25) (B) Placebo (Massage abdomen, almond oil, n = 25)
(C) No treatment (n = 25)
1 time, 15 min p = 0.008 in favor of aromatherapy Parallel/None
Cheon
(2013)
[31]
Korea
30
Pain on VAS ≥6
(A) Essential oils (Massage abdomen, nutmeg, fennel, marjoram, n = 15) (B) Placebo (Massage abdomen, almond oil, n = 15) 3 mL, 10 min, once a day from 14 days before menstruation to the starting date of next menstruation p < 0.001 in favor of aromatherapy Parallel/n.r.
Ou
(2012)
[32]
Taiwan
48
Over 18
Pain on VAS ≥5
(A) Essential oils cream (Massage abdomen, cream, lavender, clary sage, marjoram, massage, n = 24) (B) Placebo (Massage abdomen, cream, synthetic fragrance, massage, n = 24) From the end of the last menstruation continuing to the beginning of the next menstruation
Self-massage
p = 0.02 in favor of aromatherapy Compare the data of 1st cycle (pre) with the data of 2nd cycle (post)
Pain measured with NRS did not show significance
Parallel/n.r.
Pain (VRS)
Khorshidi
(2003)
[33]
Iran
60
17–25
Mild or moderate (AMVMS)
(A) Fennel oil (Oral, 1%, n = 60)
(B) Fennel oil (Oral 2%, n = 60)
(C) Placebo (n.r., n = 60) 1 time, administrated as soon as pain felt (1) p < 0.05 in favor of aromatherapy (A and B)
(2) p < 0.05 in favor of aromatherapy (A and B)
n.r. in details of treatment
n.r. in washout period
Cross-over/n.r.
Pain (LS)
Ataollahi
(2015)
[34]
Iran
110
21.4
Moderate to severe pain (VAS ≥5)
(A) Rosaceous extract (Oral, n = 55) (B) Placebo (n.r., n = 55) 10 drops twice daily or the first three days of the cycle for two consecutive cycles p = 0.001 in favor of aromatherapy Retrospective registration
Parallel/n.r.
Pain (VRS)

AMVMS: Andersch’s and Milsom’s verbal multi-dimensional scoring system; LS: Likert scale; MDQ: menstrual distress questionnaire; n.r.: not reported; NS: not significant; VAS: visual analogue scale; VRS; verbal rating scale. These controls were not placebo group and we excluded them from analysis.